市场调查报告书
商品编码
1373351
抗痤疮皮肤贴片市场规模 - 按类型(基于化学、基于草药)、按年龄组(10 至 17、18 至 44、45 至 64、65+)、按配销通路- 全球预测,2023-2032 年Anti-acne Dermal Patch Market Size - By Type (Chemical Based, Herbal Based), By Age Group (10 to 17, 18 to 44, 45 to 64, 65+), By Distribution Channel - Global Forecast, 2023-2032 |
由于痤疮病例激增,提高了对有效、便捷解决方案的需求,预计 2023 年至 2032 年抗痤疮皮肤贴片市场规模的复合年增长率将超过 6%。随着痤疮继续影响全球数百万人,消费者正在寻求传统治疗方法的创新替代方案。根据《国际皮肤病学杂誌》2022 年发表的成人痤疮综述,过去 10 年来,女性成人痤疮增加了 10%。
人们越来越认识到护肤的重要性以及对无瑕疵肤色的渴望,导致需求激增。除了这些因素之外,整个产业的研发活动也在加速,带来了满足消费者不断变化的需求的尖端进步和解决方案。
抗痤疮皮肤贴片行业按类型、年龄组、配销通路和地区进行分类。
以化学为基础的贴片类型部分预计在 2023 年至 2032 年期间将录得强劲的复合年增长率,因为这些贴片含有专门配製用于对抗痤疮的活性成分。这些创新贴片提供了有针对性的护肤方法,将成分直接输送到受影响的区域,确保增强功效。随着对化学抗痤疮皮肤贴剂的需求增加,製造商正在投资研发,以推出更有效、更有效的配方,以满足不同的皮肤类型和痤疮状况。
到 2032 年,零售配销通路部分将显着增长,因为这些贴片可以在各种零售商店(从药房和美容店到超市和线上市场)轻鬆购买。店内购买的便利性以及从训练有素的员工那里获得专家指导的能力吸引了更多的客流量。此外,零售店为消费者提供了亲自检查和选择一系列产品的机会,这对于许多购物者在选择护肤解决方案时至关重要。
由于该地区人口对护肤品的日益关注以及可支配收入的增加,预计到 2032 年,欧洲抗痤疮皮肤贴片市场将产生大量收入。此外,欧洲严格的护肤品法规和标准鼓励製造商开发安全有效的皮肤贴片。该地区的研发活动正在激增,该公司推出了迎合欧洲人口多样化皮肤类型和关注点的产品,从而塑造了该地区的行业动态。
Anti-acne dermal patch market size is predicted to witness more than 6% CAGR from 2023 to 2032 driven by the surge in acne cases which has raised the demand for effective and convenient solutions. As acne continues to affect millions worldwide, consumers are seeking innovative alternatives to traditional treatments. As per a 2022 review of adult acne published in the International Journal of Dermatology, over the past 10 years, adult acne has increased by 10% in women.
The increasing awareness about the importance of skincare and the desire for a blemish-free complexion have led to a surge in demand. Along with these factors, R&D activities across the industry are accelerating, resulting in cutting-edge advancements and solutions that meet the evolving needs of consumers.
The anti-acne dermal patch industry is classified as per type, age group, distribution channel, and region.
The chemical-based patch type segment is expected to record strong CAGR from 2023 to 2032 as these patches incorporate active ingredients that are specifically formulated to combat acne. These innovative patches offer a targeted approach to skincare, delivering ingredients directly to the affected area, ensuring enhanced efficacy. With the rise in demand for chemical-based anti-acne dermal patches, manufacturers are investing in R&D to introduce more effective and potent formulations, catering to diverse skin types and acne conditions.
The retail distribution channel segment will grow significantly through 2032 as these patches are readily available in a variety of retail stores, ranging from pharmacies and beauty outlets to supermarkets and online marketplaces. The convenience of in-store purchases and the ability to receive expert guidance from trained staff is attracting more footfall. Additionally, retails stores offer consumers the opportunity to physically inspect and select from a range of products, which is essential for many shoppers when choosing skincare solutions.
Europe anti-acne dermal patch market is anticipated to generate massive revenues by 2032 owing to the regional population's increasing focus on skincare, coupled with rising disposable incomes. Moreover, stringent regulations and standards for skincare products in Europe have encouraged manufacturers to develop safe and effective dermal patches. The region is experiencing a surge in R&D activities, with companies introducing products that cater to the diverse skin types and concerns of the European population, thereby shaping the regional industry dynamic.